96433 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Purine radicals with 2-deoxyribosyl as the saccharide radical
HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING
#2NUCLEOTIDES WITH ALPHA-IMINO PHOSPHATE GROUPS AND BRIDGING SULFURS, AND METHODS OF SYNTHESIZING AND USING THE SAME
#3NUCLEOSIDE LINE-1 INHIBITORS
#4COMPOUNDS USEFUL IN HIV THERAPY
#5DISULFIDE-LINKED REVERSIBLE TERMINATORS
#6DOUBLE-STRANDED RNA COMPRISING NUCLEOTIDE ANALOG CAPABLE OF REDUCING OFF-TARGET TOXICITY
#7METHODS OF SEQUENCING USING NUCLEOTIDES WITH 3' ACETAL BLOCKING GROUP
#8NUCLEOSIDES FOR TREATING CANCER
#92' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS
#10BIS-PROTECTED, ACTIVATED GUANINE MONOMERS
#11SOLID FORMS
#12CRYSTAL OF 4’-SUBSTITUTED NUCLEOSIDE, AND PREPARATION METHOD THEREFOR, COMPOSITION THEREOF AND USE THEREOF
#13METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS
#14CRYSTAL OF 4’-SUBSTITUTED NUCLEOSIDE, PREPARATION METHOD THEREFOR, COMPOSITION CONTAINING THE SAME, AND USE THEREOF
#15INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE (NNMT)
#16METHOD FOR PREPARING ANTI-HIV DRUG ISLATRAVIR
#17METHODS OF SEQUENCING USING 3' BLOCKED NUCLEOTIDES
#18THERAPEUTIC OLIGONUCLEOTIDES
#19Methods of sequencing using nucleotides with 3′ acetal blocking group
#20Cordycepin-based derivatized compound with anti-tumor effect
#21HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING
#22Compounds useful in HIV therapy
#23Substituted nucleosides, nucleotides and analogs thereof
#24Polymerizable compound, compound, and method for producing boranophosphate oligomer
#25Therapeutic oligonucleotides
#26Methods for treatment and prophylaxis of HIV and AIDS
#272′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
#28INHIBITORS OF ADENYLATE-FORMING ENZYME MENE
#29Crystalline forms of an NRTTI compound
#30Disulfide-linked reversible terminators
#31DRUG COMPOUND AND PURIFICATION METHODS THEREOF
#32Phosphorous protecting groups and methods of preparation and use thereof
#33Nucleosides and nucleotides with 3′ acetal blocking group
#34METHODS FOR ASSEMBLING DNA MOLECULES
#35Production method for guanosine derivative having fluorine atom-containing functional group at position 8 and application thereof
#36Substituted nucleosides, nucleotides and analogs thereof
#37PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
#38Nucleic acid prodrugs
#392′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
#40Drug compound and purification methods thereof
#41Methods for the treatment and prophylaxis of HIV and AIDS
#42Modified nucleosides or nucleotides
#43Substituted nucleosides, nucleotides and analogs thereof
#44Phosphoramidate nucleoside derivatives as anticancer agents
#45PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS
#46Polymerizable compound, compound, and method for producing boranophosphate oligomer
#47Therapeutic oligonucleotides
#48Phosphorous protecting groups and methods of preparation and use thereof
#493′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
#50Drug compound and purification methods thereof
#51Substituted nucleosides, nucleotides and analogs thereof
#52HCV POLYMERASE INHIBITORS
#53Substituted nucleosides, nucleotides and analogs thereof
#54High intensity labeled reactant compositions and methods for sequencing
#55Nucleic acid prodrugs
#56Polymer
#57Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide
#58Methods for assembling DNA molecules
#59Processes and intermediates for preparing anti-HIV agents
#60Methods for the treatment and prophylaxis of HIV and AIDS
#61Oligonucleotide having non-natural nucleotide at 5′-terminal thereof
#626-aryl-9-glycosylpurines and use thereof
#633′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
#646-aryl-9-glycosylpurines and use thereof
#65MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF
#662′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds
#67Modified nucleosides or nucleotides
#68Synthesis of bicyclic nucleosides
#69Substituted nucleosides, nucleotides and analogs thereof
#70Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces
#71Substituted nucleosides, nucleotides and analogs thereof
#723′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
#73HCV polymerase inhibitors
#74Processes and intermediates for preparing anti-HIV agents
#75Nucleotide derivative or salt thereof, nucleotide-derived 5′-phosphate ester or salt thereof, nucleotide-derived 3′-phosphoramidite compound or salt thereof, and polynucleotide
#762′,4′-substituted nucleosides as antiviral agents
#77Mutagenic nucleoside analogs and uses thereof
#78Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV
#79Modified nucleosides or nucleotides
#80Phosphorous protecting groups and methods of preparation and use thereof
#81Exocyclic nitrogen atom protected nucleoside and method for producing and using the same
#82Nucleic acid chemical modifications
#83Processes and intermediates for preparing anti-HIV agents
#843′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
#85Oligonucleotide with protected base
#86Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method
#87Uses of dihydro bases
#88Substituted nucleosides, nucleotides and analogs thereof
#89Substituted nucleosides, nucleotides and analogs thereof
#90Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
#911,2,3-Triazolyl purine derivatives
#92Oligonucleotide with protected base
#93Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions
#94Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
#95Compounds for treating bacterial infections
#96Bicyclic nucleosides and oligomeric compounds prepared therefrom
#97Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
#983′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
#99RNA including nucleoside compound, method for regulating amount of protein produced from the RNA, and nucleoside compound
#1005′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
#101Processes and intermediates for preparing anti-HIV Agents
#102Artificial fluorescent bases
#1032′,4′-substituted nucleosides as antiviral agents
#104Bridged artificial nucleoside and nucleotide
#105Guanosine-rich modified oligonucleotides and antiproliferative activity thereof
#106Process of making cladribine
#107COMPOUNDS FOR THE SYNTHETIC INTRODUCTION OF N-ALKYL NUCLEOSIDES INTO DNA OLIGONUCLEOTIDES
#108NUCLEIC ACID DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF
#1093′-azido purine nucleotide prodrugs for treatment of viral infections
#1102-fluorinated riboses and arabinoses and methods of use and synthesis
#111Nucleic acid chemical modifications
#112Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
#113ANTIVIRAL AGENTS
#114Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
#115Reagents for reversibly terminating primer extension
#116Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
#1172'-F MODIFIED RNA INTERFERENCE AGENTS
#118Method for producing phosphate-bridged nucleoside conjugates
#119NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF
#120Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method
#121Nucleoside Phosphonate Analogs
#122Process for the preparation of cladribine
#123RNA-selective hybridization reagent and use of the same
#124Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis
#125AZIDO PURINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS
#126SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS
#127Purine nucleoside derivative modified in 8-position and medical use thereof
#128PROTECTED NUCLEOTIDE ANALOGS
#129Inactivators of O6-alkylguanine-DNA alkyltransferase
#130Convertible nucleoside derivatives
#1312, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
#132Selective inhibitors of translesion DNA replication
#133Caged nucleotides and oligonucleotides and their application
#134Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides
#135THIONUCLEOSIDES AND PHARMACEUTICAL APPLICATIONS
#136Process of making 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides and intermediates therefor
#137Process for production of crystal of purine nucleoside compound
#138Oligonucleotides comprising a non-phosphate backbone linkage
#1392',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS
#140Oligonucleotides comprising a non-phosphate backbone linkage
#141Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine
#142Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use
#143Nucleoside derivatives
#144PHARMACEUTICAL COMPOSITIONS OF SILICON-CONTAINING SUBSTITUTED ADENOSINE NUCLEOSIDE AMIDE ANALOGS
#145Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
#146Process for the preparation of didanosine using novel intermediates
#147Reagents for the improved synthesis of isoguanosine containing oligonucleotides
#148Adenosine Analogs Useful as Anti-Bacterial and Anti Protozoan Agents
#149Silyl linker for solid-phase synthesis of nucleic acid
#150Nucleoside releasing functional unit through oxidation and process for producing oligonucleotide containing thereof
#151Purinenucleoside derivative modified in 8-position and medical use thereof
#152Selective O-acylation of nucleosides
#153Method for the preparation of 2-halo-2′-deoxyadenosine compounds from 2′-deoxyguanosine
#154Oligonucleotides comprising a non-phosphate backbone linkage
#155Thionucleoside-S-nitrosyl derivative
#156Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
#1574'-thionucleotide
#158Process for producing phosphoroamidite
#159Nucleoside phosphonate analogs